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The COll/COt8 family of leukocyte adhesion-promoting 
proteins is comprised of three members, each composed of a 
shared beta subunit (COt8) noncovalently associated with 
unique alpha subunits (COlla, COltb and COltc respec-
tively). Such three heterodimers, named LFA-I (COlla/ 
COt8), H-Mac-l (COllb/COt8) and gp150,95 (COllc/ 
COI8), are involved in mediating leukocyte adhesion in 
virtually all phases of the immune responses. Since Langer-
hans cells are regarded as cutaneous leukocytes, we investi-
gated the expression of the members of the COII/C018 
family on Langerhans cells. 
A vast series of immunostaining procedures was carried 
out, using monoclonal antibodies anti-COlla, -COllb, 
-COlle, and -CD18. Normal skin frozen sections and epi-
dermal sheets were investigated by immunohistology and 
immunofluorescence; suspended freshly isolated epidermal 
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IgG antibody 
cells were processed using immunogold techniques, per-
formed in both transmission and scanning electron micros-
copy, including double labeling procedures and semiquanti-
tative analysis of the labeled cells. The results demonstrated 
the expression on the membrane of Langerhans cells of the 
CDltb, COlle and COl8 antigens, thus indicating that at 
least both the H-Mac-l (C011b/C018) and the gp 150,95 
(COllc/C018) members of the COII/COI8 family are 
detectable on the cell surface of human resting Langerhans 
cells. Since both such moieties serve as adhesion molecules in 
(a) cell-cell interactions and in (b) leukocyte migration and 
localization, the present results suggest that H-Mac-l and gp 
150,95 might display a key role (a) in promoting interactions 
between Langerhans cells and other cells, and (b) in guiding 
the migration and localization of Langerhans cells. ] Invest 
Dermatol 93:60 - 69, 1989. 
GAM-G40: 40-nm sized colloidal gold-conjugated goat antimouse 
IgG antibody 
gp 150,95: glycoprotein 150,95 
HBSS: Hanks's balanced salt solution 
H-Mac-l : human Mac-1 
IEM: immunoelectronmicroscopy 
IF: immunofluorescence 
IG: immunogold 
IP: immunoperoxidase 
LC: Langerhans cell(s) 
LFA-l : lymphocyte function-associated antigen 1 
LM: light microscopy 
moAb: monoclonal antibody(ies) 
PBMC: peripheral blood mononuclear cells 
PBS: phosphate-buffered saline 
RPMI-FCS: RPMl-1640 medium with 10% FCS 
SEM: scanning electron microscopy 
TEM: transmission electron microscopy 
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S everallines of evidence recently indicated that c~lI. adhe-sion, cell migration, and lymphocyte help and ktlllng all involve related cell surface receptors. Indeed, three recep-tor families, namely, (1) the VLA, fibronectin receptor family; (2) the gp lIb/lIla, vitronectin receptor family; 
and (3) the COll/COI8 family, are conserved subgroups in a 
superfamily of adhesive receptors called "integrins" [1,2) . The 
members of the first and second integrin families are consistently 
extracellular matrix receptors [1,3). 
The third integrin family (COll/C018 family) is involved in 
cellular adhesion in virtually all phases of the immune responses 
[4,5), and consists of three non-covalently associated alphajbeta 
heterodimers, which share an identical beta subunit, and are distin-
guished by three different alpha s~bunits [~). In fact.' the first heter-
odimer, called lymphocyte function-associated antigen 1 (LFA-l), 
has an alpha subunit (COlla) of 180kO (alpha L) [5 - 15); the sec-
ond heterodimer, called human-Mac-l (H-Mac-l), has an alpha 
subunit (CD lIb) of 165 kO (alpha M) [6,7,16 - 20]; the third heter-
odimer, called glycoprotein 150,95 (gp 150,95), has an alpha sub-
unit (COllc) of 150 kO (alpha X) [6,7,12,17,21-24]. The three 
heterodimers share an identical beta subunit (COl8) of 95 Kd 
[6,7,12,25-28) (Table I). It is now clear that the COlla-b-c 
subunits are structurally related transmembrane polypeptides with 
long extracellular domains including divalent cation-binding se-
quences; the COl8 subunit is an integral membrane polypeptide 
whose extracellu lar portion contains four cysteine-rich homolo-
gous repeats. 
The three members of the COll/COI8 family are involved in 
leukocyte adhesive interactions. In fact, the first member, i.e., 
LFA-l (CDIla/CDI8), is expressed on most leukocytes and espe-
cially on lymphocytes and functions particularly in lymphocyte 
help, killing and adhesion [5 -15,25-28); the second member, i.e., 
H-Mac-l (COllb/CDI8), and the third member, i.e., gp 150,95 
(COllc/CD18), are both expressed on leukocytes generally other 
than lymphocytes, and especially on monocytes, tissue macrophages 
and neutrophils, and function as adhesion molecules in cell-cell and 
cell-substrate interactions [6,7,12,16 -28). 
Langerhans cells (LC) are fascinating, bone-marrow-derived 
[29), dendritic epidermal cells which play a key role in the 
immunological functions of the skin; they can be considered epider-
mal leukocytes [30 ,31) . We therefore intended to examine whether 
LC could express, as well as other circulating and tissue leukocytes 
do, adhesive molecules on their plasma membrane. 
By means of an exhaustive series of immunostaining procedures, 
we demonstrated that human resting LC clearly express at least both 
the second (CDllb/C018) and the third (COllc/COl8) mem-
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bers of the COll/C018 family, and propose the hypothesis that 
such expressions could possibly be related to LC adherence to other 
cell types and to LC migration and localization. 
MATERIALS AND METHODS 
Normal Human Skin Two types of skin samples were utilized, 
namely skin biopsies and skin slices. Skin biopsies were removed 
from clinically normal-appearing skin of ten healthy volunteers 
whose age ranged from 17 to 61 years. The specimens were ob-
tained from either sun-protected or sun-exposed areas. Skin slices 
were obtained from clinically normal-appearing skin of ten healthy 
subjects whose age ranged from 21 to 58 years, removed from either 
breast or abdomen areas by plastic-surgery reduction operations. 
hnmunoreagents 
Primary (Molloclona{) Alltibodies: The anti-COlla, -CD11b, 
-CDllc, and -C018 monoclonal antibodies (moAb) used in this 
study are listed in Table 1. In the double immunogold (IG) labeling 
experiments, a further moAb was used, namely the 5-nm sized 
colloidal gold-conjugated anti-HLA-OR moAb (E.Y. Laboratories, 
Inc., San Mateo, CA). 
Secolldary Alltibodies: The following secondary sera and antibodies 
were used: (1) peroxidase-conjugated goat antimouse Ig serum 
(Oakopatts, Copenhagen, Denmark), for immunoperoxidase (IP) 
staining in light microscopy (LM); (2) fluorescein isothiocyanate-
conjugated F(ab'h goat antimouse Ig antibody (Tago, Inc., Burlin-
game, CA), for immunofluorescence (IF); (3) 15-nm sized colloidal 
gold-conjugated goat anti mouse IgG antibody (GAM-G 1 5, Janssen 
Pharmaceutica, Beerse, Belgium), for IG-immunoelectronmicros-
copy (lEM) labeling in transmission electron microscopy (TEM); 
(4) 40-nm sized colloidal gold-conjugated goat antimouse IgG 
antibody (GAM-G40, Janssen). for IG-IEM labeling in scanning 
electron microscopy (SEM). 
Control Reagolts: Control immunoreagents included: (1) purified 
mouse unreactive IgG fraction of a}?pro{'riate isotype (Chemicon 
International Inc., El Segundo, CAl; (2) purified unlabeled goat 
antimousc IgG antibody (Chemicon); (3) unconjugated colloidal 
gold particles, either 40-nm, 15-nm or 5-nm sized, respectively 
(Ortho Pharmaceutical Co., Raritan, NJ); (4) purified unlabeled 
anti-HLA-DR moAb (Becton-Dickinson Monoclonal Center, 
Mountain View, CA); (5) purified anti-Leu6 (COla) moAb 
(Becton-Dickinson). 
Processing of Skin Biopsies Fresh biopsy samples were divided 
in two parts. The first portion was immediately frozen in liquid 
Table I. Distribution on Leukocytes of the Three Members of the Adhesion-promoting CD11/CD18 Family, Namely LFA-I 
(COlla/CDI8). H-Mac-l (CD1lb/CDI8) and gp 150,95 (CDllc/COl8), and Monoelona] Antibodies Used in This Study 
to Identify the Subunits of the CDl1/C018 Family 
Cluster of Differentiation Subunit kD Cellular Reactivity 
COlla alpha L chain 180 T and B lymphocytes (a). 
most other leukocytes 
CDltb alpha M chain 165 monocytcs, macrophagcs, 
NK cells, granulocytes. 
subset of T8 lymphocytes 
COlle alpha X chain 150 monocytes, macrophages (a), 
NK cells, granulocytes, 
2% lymphocytes 
CDlS common beta chain 95 most leukocytes 
(a) Cells expressing large amounts of antigen. . .. . 
(b) Code number 720, from the third international Workshop on human leukocyte dtfFerentlatlon antigens (Oxford. 1986). 
(c) Code number 709. from the third international Workshop on human leukocyte differentiation antigens (Oxford. 1986). 
(d) Decton Dickinson Monoclonal Center. Mountain View, CA, USA. 
(e) Code number 645. from the third international Workshop on human leukocyte differentiation antigens (Oxford. 1986). 
(f) Orrho Pharmaceutical Co. Raritan. NJ, USA. 
(g) Dakopatts. Copenhagen. Denmark. . .. . 
(h) Code number 706. from the third international Workshop on human leukocyte dIfferentiation antIgens (Oxford. 1986). 
moAb Used in This Study 
TS 1/22.1.1.17 (b) 
MHM24 (c) 
Anti-Leu-15 (d) 
60.1 (e) 
OK.M1 (f) 
Anti-C3bi (g) 
Anti-Leu-M5 (d) 
60.3 (h) 
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nitrogen, then sectioned 4 - 5-llm thick by a cryostat, and prepared 
for the in situ IP studies in LM. The second portion was trimmed, 
split-cut and floated on a 0.25% solution of trypsin (Gibco, Paisley, 
U.K.) in Hanks' balanced salt solution (HBSS, Gibco), 45 min at 
3rc, and the epidermal sheets were prepared for the IF studies. 
lmmunoenzymatic Studies on Vertical Sections After block-
ing the endogenous peroxidases, a double-layer procedure was per-
formed on the cryostat sections, using in the first step the moAb of 
the CDll/CDl8 panel (and on serial sections, as control, the anti-
COla moAb) usually diluted 1: 40 in PBS for 45 min at room 
temperature, and, in the second step, the peroxidase-conjugated 
secondary antibody diluted 1: 10 in PBS, for 60 min at room tem-
perature. The diaminobenzidine reaction then reveaJed the peroxi-
dase activity. The immunohistologic method used is extensively 
described elsewhere [32]. 
Immunofluorescence Studies on Epidermal Sheets The IF 
staining was carried out slightly modifying the method previously 
described [33]. Briefly, epidermal sheets, after extensive washes in 
phosphate-buffered saline (PBS), were incubated, for the indirect 
irnmunostaining, with (first layer) the anti-CDll/CDl8 series of 
moAb (or the control anti-COla moAb on separate sheets), diluted 
1 : 40 in PBS, for 6 h, followed by (second layer) the fluorescein 
isothiocyanate-conjugated secondary antibody, diluted 1: 10 in 
PBS, for 12 h. After washes in PBS and mounting in PBS/glycerol, 
the sheets were examined under a Zeiss £1uorescence microscope in 
epi-illumination. 
Processing of Skin Slices Skin removed by plastic surgery was 
trimmed of fat and thereafter split-cut by a keratotome, set at 0.4 
mm. The resulting fresh slices were removed and immediately uti-
lized for the preparation of the epidermal cell (Ee) suspension. 
Epidermal Ce)) Suspension and Langerbans CeJl Enrich-
ment The slices were floated, dermal side down, on 0.25% trypsin 
in HBSS, for 45 min at 3rC, thus allowing the separation of the 
epidermis from the dermis. The resulting epidermal sheets were 
treated according to a method described elsewhere [34]. Briefly, the 
sheets were pooled, shaken and pipetted in HBSS supplemented 
with 10% heat-inactivated fetal-calf serum (FCS, Gibco). The re-
sulting suspended cells were filtered, sedimented by centrifugation, 
resuspended, and washed in RPMI-1640 medium with 10% FCS 
(RPMI-FCS). 
For LC enrichment, EC dispersed in RPMI-FCS were layered on 
the Ficoll-Hypaque (Pharmacia Fine Chemicals, Uppsala, Sweden) 
gradient, and subsequently centrifuged for 10 min at 400 g. EC at 
the interface were thereafter collected and resuspended in RPMI-
FCS. The viability, assessed by eosin exclusion, was higher than 
90%. Such LC-enriched EC suspensiollS were prepared for the IG-
IEM procedures, either for TEM or for SEM. 
IMMUNOGOLD LABELING PROCEDURE FOR 
TRANSMISSION ELECTRON MICROSCOPY 
A previously described procedure, with slight modifications, was 
used [35,36] for the IG-TEM staining. Briefly, LC-enriched EC 
(5 X 106 /ml), after prefixation with 0.1 % glutaraldehyde in 0.1 M 
cacodylate buffer pH 7.4 for 10 min, and quenching aldehyde 
groups by 50 mM glycine, were washed in PBS-O.l % bovine serum 
albumin (BSA, Sigma Chemical Co., St. Louis, MO) pH 7.2, and 
subsequently subjected to a blocking pretreatment including 
PBS-l% BSA, 0.2% sodium azide, and 10% decomplemented 
human AB serum for 30 min. After washings in PBS-O.l % BSA pH 
7.2, the moAb were applied to specimen cells, diluted 1 : 40 in PBS 
with 1 % BSA pH 7.2,30 min at 4 C. After washes in PBS with 0.1 % 
BSA pH 7.2, the GAM-GIS secondary antibody was used, diluted 
1 : 10 in 1 % BSA buffer (0.05 M Tris saline buffer containing 1 % 
BSA and 0.02 M sodium azide) pH 8.2, for 60 min. 
After washings in 0.1 % BSA buffer pH 8.2, EC specimens were 
divided into two parts: one of them was directly prepared for the 
TEM ultrastructural studies, the other one was introduced to the 
double IG labeling procedure. 
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Double Immunogold Labeling Procedure EC, stained by 
(first step) moAb and (second step) GAM-GIS according to the 
above-mentioned single IG labeling procedure, were subjected to a 
(third step) blocking incubation with a mouse unreactive IgG frac-
tion (Pel-Freez Biologicals, Rogers, AZ), diluted 1 : 2 in PBS with 
0.1 % BSA pH 7.2, for 30 min at 4 0 C, to block the still-available 
antigen binding sites of the GAM-GIS. Finally, the (fourth step) 
S-nm sized gold-conjugated anti-HLA-DR moAb was used, diluted 
1 : 40 in PBS with 1 % BSA pH 7.2, 60 min. Such double-labeled 
EC, after washings in PBS with 0.1 % BSA pH 7.2, were then 
prepared for the TEM ultrastructural studies. 
Immunogold Labeling Procedure for Scanning Electron 
Microscopy The IG labeling for SEM was carried out according 
to a previously described technique [37,38] . Briefly, the LC-
enriched Ee were allowed to settle by placing a drop of the cell 
suspension on glass coverslips, pretreated by 0.1 % poly-I-lysine, in a 
moist chamber, for 30 min at room temperature. After attachment, 
prefixation with 0.2% glutaraldehyde in PBS pH 7.2 for 5 min, 
quenching of aldehyde groups by 0.1 % glycine in PBS for 10 min, 
and blocking pretreatment by PBS pH 7.2 containing 1 % BSA, 
0.2% sodium azide (PBS-BSA buffer) and 10% decomplemented 
human AB serum, EC were then subjected to an indirect IG proce-
dure, since they were incubated first with the moAb diluted 1 : 40 in 
PBS-BSA buffer, 30 min at room temperature, and, after washings 
in PBS-BSA buffer, with the GAM-G40 secondary antibody, di-
luted 1 : lOin 1 % BSA buffer pH 8.2, 60 min at room temperature. 
After washings in 0.1 % BSA buffer, pH 8.2, EC were prepared for 
SEM ultrastructural studies. 
Transmission Ultrastructural Studies The EC suspensions 
prepared for TEM procedures, both single and double IG labeled, 
were washed in PBS, pH 7.2, and then fixed with 1 % glutaralde-
hyde in 0.1 M cacodylate buffer, pH 7.4. Cells were subsequently 
packaged in 2% Bacto-Agar (Difco Laboratories, Detroit, MI) at 
45 0 C, postfixed in potassium ferricyanide-reduced osmium tetrox-
ide, dehydrated in acetone, and finally embedded in Durcupan 
ACM (Fluka, Buchs, Switzerland). Ultrathin sections were 
obtained by a LKB III ultramicrotome and were examined, either 
post-stained with lead citrate and uranyl acetate or absolutely 
uncounterstained, at a Philips EM 300 electron microscope. To 
evaluate the gold labeling at the TEM level, a cell was considered 
positive when at least three gold particles were observed attached at 
its plasma membrane per section [39] . 
Scanning Ultrastuctural Studies The EC prepared for SEM 
procedures were washed in PBS pH 7.2, post fixed in 2% glutaralde-
hyde in PBS, dehydrated in graded alcohols, critical-point dried 
from CO2, coated with 200 A of evaporated carbon, and observed at 
a Philips 505 scanning electron microscope [37,38] . 
Control Experiments 
Controls Jor Methods Specificity: For the indirect methods, including 
IP on vertical sections in LM, IF on epidermal sheets, IG single 
labeling in TEM and IG labeling in SEM, the negative controls 
consisted of: (1) replacement of the moAb by mouse unreactive IgG 
of appropriate isotype; (2) replacement of the moAb by buffer solu-
tion; and (3) inhibition of staining by preincubation, before the 
conjugated goat antimouse IgG antibody, with the unlabeled goat 
anti mouse IgG antibody. An additional negative control in the IEM 
(both in TEM and in SEM) studies was the replacement of the 
GAM-GIS (TEM) and GAM-G40 (SEM) by unconjugated gold 
particles of the same size. Controls for the four-step double IG 
procedure included, together with the above-mentioned controls, 
inhibition of the 5-nm sized gold staining by preincubation, before 
the 5-nm sized gold-conjugated anti-HLA-DR moAb, with the 
unconjugated anti-HLA-DR moAb; and replacement of the 5-nm 
sized gold-conjugated moAb by unconjugated 5-nm sized gold 
particles. 
Controls Jor Immunoreagents: Positive controls for moAb were 
carried out on normal human lymph node, using IF and IP-LM 
immul1ostainings. 
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In addition, peripheral blood mononuclear cells (PBMC) from 
healthy donors were subjected to the same IG-IEM methods used 
for EC, although they were slightly modified for PBMC processing 
according to our previously described procedures, both in TEM 
[35,36] and in SEM [37]. to reveal the ability of the immunoreagents 
to detect (1) the COlla- and C018-positivity of most PBMC, (2) 
the COllb- and COlIc-positivity of monocytes, and (3) the 
COI1b-positivity of a subset ofT8 lymphocytes (Table I). 
Later, in situ IEM studies were performed on untrypsinized, 
paraformaldehyde slightly prefixed, normal human-skin frozen 
sections to confirm the COll/C018 results obtained on trypsin-
ized, glutaraldehyde prefixed, suspended EC using a pre-embed-
ding in situ IG method in TEM developed by us [40,41]. 
A final control, performed in IEM, to confirm the H-Mac-l and 
gp 150,95 positivities of LC, was carried out by a blocking experi-
ment incubating LC-enriched EC first with the anti-COla moAb 
(blocking step) and subsequently with the anti-COIl b, -COllc 
and -COl8 moAb. 
Semi-quantitative Analysis of the Labeling A semi-quantita-
tive evaluation of the number of binding sites at the surface of 
positive cells [35,42] was performed at the transmission electron 
microscope, counting the number of gold particles along the cir-
cumference of the cell surface of the COll/C018-positive LC.In 
fact, the number of gold granules per section of cell surface was 
scored, analyzing 40 randomly chosen single-labeled LC sectioned 
near their midplane [35,42] . Finally, the means and the standard 
errors were calculated. 
RESULTS 
Light Microscopy and Fluorescence Immunostainings Im-
munohistologic studies in skin vertical cryostat sections first re-
vealed that absolutely no dendritic COlla-positive EC were detect-
able. On the other hand, the same IP technique resulted only in a 
faint visualization of both COllb- and C018-positive dendritic 
EC; moreover, serial sections revealed that the COlI b- and COl8-
positive EC were less numerous in comparison to the COla-posi-
tive Ee. By contrast, a good visualization of well-reactive COllc-
positive dendritic EC was achieved; further, serial sectioning 
revealed that the estimated number of the COla-positive EC was 
similar to that of the COlle-positive Ee. 
Sheet preparations in IF revealed that practically no dendritic 
COlla-positive EC were visible. On the contrary, some dendritic 
COllb- and COl8-positive EC were observed, although the stain-
ing results were weak. However, a good visualization of COllc-
positive dendritic EC was achieved (Fig I), and their estimated 
number was similar to that of the COla-positive cells of control 
sheets. 
SINGLE (Figs 2,3,4,5) ANO OOUBLE (Fig 6) 
IMMUNOGOLO STAININGS IN TRANSMISSION 
ELECTRON MICROSCOPY 
Positive cells within the LC-enriched EC suspension were identi-
fied, at the TEM level, by the presence of electron-dense gold parti-
cles scattered along the circumference of the cell section (Figs 2 - 4). 
Figure 1. Epidermal sheet preparation. Immunofluorescence labeling of 
COlle-positive dendritic epidermal cells. Bar = 50 11m. 
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Figure 2. Immun~gold label5ng in transmission electron microscopy of a 
Langerhans cell with an antl-COltb moAb. A : The Langerhans cell is 
weakly, but clearly, labeled. The punctate pattern of the gold particles scat-
~ered along the cell surface is indicated by the arrows. The rectangulated area 
IS conSIdered . enlarged, in B. Bar = 111m. B: At high magnification. two 
gold granules. apposed to an expansion of the plasma membrane are well 
visible. Bar = 0.2 11m. ' 
The labeling dealt with a variable number of randomly dispersed 
and spatially separated goldrarticles, single or in very small clusters, 
apposed at the periphery 0 the positive cells (Figs 2 - 4), while in 
the cytoplasm no gold granules were observed (Figs 2 - 5). 
Keratinocytes were virtually COl1a-, COllb-, COllc- and 
COI8-negative. Birbeck granules bearing LC were consistently 
COlla-negative. However, all the observed Birbeck granules 
bearing LC were clearly gold-reactive with both the anti-COI1b 
(Fig 2) and the anti-COl8 (Fig 4) moAb, and even strongly gold-
reactive with the anti-COlIc moAb (Fig 3). 
The double IG labeling procedure revealed that all the observed 
HLA-OR-positive EC (Fig 6) shared the anti-C011b, -COlIc (Fig 
6B), -COl8 (Fig 6C) reactivities, since gold particles of both S-nm 
and 1S-nm sizes were visible along the surface of such double-
labeled EC (Figs 6B, 6C). However, gold particles of 15-nm sizes 
did not associate with the particles of 5-nm size when the anti-
COlla moAb were used (Fig 6A). 
ImmutJogold Staining in Scanning Electron Microscopy 
(Fig 7) In the standard secondary electron imaging mode, EC 
showing the SEM morphology of LC [38] were consistently 
COlla-negative, but COllb- (Fig 7A), C01Ic- (Fig 7B) and 
CD18-positive, as demonstrated by gold particles, as white dots, 
distributed on the whole cell membrane (Figs 7 A, 7B). It was thus 
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Figure 3. Immunogold labeling in transmission electron microscopy of a 
Langerhans cell with the anti-CDllc moAb. A : The Langerhans cell is 
strongly labeled. In fact, numerous gold granules (arrows) decorate, in a 
punctate pattern at this low magnification, the cell membrane. The rectan-
gulated area is considered, enlarged, in B. Bar = 111m. B: At high magnifi-
cation, some gold granules apposed to the cell surface are easily observed. 
Bar = 0,2 11m. 
clear that large numbers of gold granules were visible on the surface 
of the COIIb- (Fig 7A) and COl8-positive LC, whereas the 
COlle-positive LC showed a higher number of gold particles on 
the cell surface (Fig 7B). The keratinocytes (Fig 7C) were COIIa-, 
CDllb- , CDl1c- and CD18-llegative. 
Controls Controls for method specificity including immuno-
staining techniques in LM, IG-TEM procedures (Fig 5), and IG-
SEM procedures (Fig 7C) all proved negative. 
Controls for immunoreagents were positive. Specifically, anti-
CD11a moAb stained, within the PBMC population, lymphocytes 
and, although to a lesser extent, NK cells and monocytes; anti-
CD1tb and -CDt1c stained monocytes and NK cells; anti-CD11b 
additionally stained a small subset of lymphocytes, as described 
[19,20]; anti-CD18 stained most PBMC. 
In addition, the in situ IEM studies on normal human skin con-
firmed the COl tb- , COllc- and COl8-positivity of unisolated 
LC, as recently shown by us [41] . 
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Finally, the blocking experiment showed that the anti-CDI1b, 
anti-CDIIc and anti-CDl8 moAb reacted with LC in a manner 
strictly similar to that observed in the experiments performed 
without blocking. 
SEMIQUANTITATIVE ESTIMATION OF THE CDll/ 
C018 EXPRESSION BY LANGERHANS CELLS 
The comparative quantification of gold particles fixed on the 
plasma membrane of LC per cell section (midplane) [35,42] after 
labeling in TEM with moAb detecting the members of the CDll/ 
COl8 family are shown in Table II. Since, as mentioned above, in 
TEM a cell is considered positive when at least three gold particles 
are linked to its section surface [39], it is clear that this semiquantita-
tive analysis demonstrates that LC are virtually CD11a-negative 
(0.3 ± 0.6 particles per LC section), both CDt Ib (6.9 ± 10.1 parti-
cles per LC section) and CD18 (7.5 ± 4.9 particles per LC section) 
-positive, and strongly CD1Ic-positive (35.0 ± 27.7 particles per 
LC section). 
DISCUSSION 
The present investigation demonstrates the reactivity of the LC 
plasma membrane with the anti-CDllb, anti-CDIIc, and anti-
CDl8 moAb, thus confirming our preliminary findings [43-46]. 
As mentioned above, the CDllb subunit is non-covalently asso-
Figure 4. Immunogold labeling in transmission electron microscopy of a 
Langerhans cell with the anti-CDl8 moAb. A : The Langerhans cell is 
weakly, but clearly, labeled. Gold particles (arrows) are faintly visible at this 
magnification, in a punctate pattern. The rectangulated area is considered, 
enlarged, in B. Bar = 0,5 j.tm. B: At high magnification, two gold granules 
apposed to the cell membrane are well evident. Bar = 0,2 11m. 
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Figure 5. Immunogold labeling in transmission electron microscopy of a 
Langerhans cell with unreactive mouse IgG of apfropriate isotype, instead of 
moAb (negative control). A : The Langerhans cel is unlabeled, since no gold 
particles are visible along the cell surface. The rectangulated area is consid-
ered, enlarged, in B. Bar = I pm. B: Even at high magnification, absolutely 
no gold particles are observed on the plasma membrane. Bar = 0,5 pm. 
ciated with C018 subunit to form the heterodimer H-Mac-l 
(COllb/COl8) [6); similarly, the COllc subunit is non-cova-
lently associated with the COl8 subunit to form the heterodimer gp 
150,95 (COllc/C018) [6]. On the other hand, the three members 
(LFA-l, H-Mac-l and gp 150,95) of the COlt/COIS family are 
usually recognized employing the moAb detecting the subunits 
(COlla, COllb, COllc and C018) which compose them 
[7,18,21,24]. In this investigation, therefore, we assess the expres-
sion on the membrane of human epidermal resting LC of at least 
the second (H-Mac-1) and the third (gp 150,95) members of the 
adhesion-promoting COll/C018 family. 
In the current study we show that LC do not apparently express 
the COlla subunit, since, using two anti-COlla moAb 
(TS/22.1.1.17 and MHM24), all the immunostainings including 
the sensitive [35,36,42] IG-TEM method and even the highly sen-
sitive [37,38] IG-SEM method gave virtually n~ga~ive re~ul~s. It 
seems therefore [7,18,21,24] possible, although wlthm the hmltS of 
the immunostaining methods herein used, to conclude that LC 
plasma membrane does not seemingly express the LFA-l (COlla/ 
C018) glycoprotein, since, though the COl8 subunit is certainly 
expressed by LC surface [45, present study], LC membrane lacks 
indeed COlla. On the other hand, a hypothetical LFA-l expres-
sion by LC, which may be regarded as an epidermal leukocyte 
[30,31], might, to some extent, have been expected, since the LFA-l 
moiety [5), although especially expressed by lymphocytes [8 -
11,14,15], seems indeed to be present on most leukocytes including 
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Figure 6. Double immunogold staining in transmission electron micros-
copy of Langerhans cells with moAb detecting the subunits of the COlli 
C018 family (indirectly labeled by lS-nm sized gold particles) and anti-
HLA-OR moAb (directly labeled with S-run sized gold particles); 
poststained sections. A : Detail of a Langerhans cell incubated with an anti-
COlla moAb and with anti-HLA-OR moAb. The cell is COlla-negative, 
since no gold particles of IS-nm size are visible along the cell surface. By 
contrast, many S-nm sized gold particles decorate the membrane, indicating 
the HLA-OR-positivity. Bar = 0,1 J.l.m. B: Detail of a double-labeled Lan-
gerhans cell. The COlle antigens are detected by the IS-nm sized gold 
particles (arrows) , whereas the HLA-OR antigens are detected by the S-nm 
sized gold particles. Biu- = 0,1 pm. C: Detail of a double-labeled Langerhms 
cell. The IS-run sized gold particles (only one in this area: arrow) indicate the 
presence of the COl8 antigen, while the numerous S-nm gold particles 
indicate the presence of HLA-OR antigens. Bar = 0,1 pm. 
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monocytes [13]. Certainly, a hypothetical CDlla expression by 
LC, e.g., possibly detectable by immunoprecipitation studies or 
using moAb other than those utilized in the present study, cannot be 
ruled out: in fact, tbe CDlla epitopes recognized by the moAb used 
in this investigation might theoretically be either glutaraldehyde 
and/or trypsin sensitive, or somehow masked, as demonstrated for 
other epitopes [47]. However, the moAb used here actually suc-
ceeded in recognizing the CDlla subunit of CDl1a-positive leu-
kocytes including the PBMC of the positive controls performed in 
the current study. In addition, a mounting body of evidences exists 
indicating that the most important role of the LFA-l heterodimer is 
to strengthen adhesion of lymphocytes (expressing indeed the 
LFA-l moiety) to cells bearing specific antigens, perhaps by binding 
to molecule {presumably the "ICAM-t" molecule} on the antigen-
presenting cell or target cell, thereby increasing the range of avidi-
ties over which antigen-specific interactions can be effective [48-
52]. It seems therefore conceivable that the LFA-l expression has to 
be expected on the membrane of lymphocytes interacting with LC 
rather than on the membrane of the antigen-presenting LC. Instead, 
LC should express, other than LFA-l, a ligand for the lymphocytic 
LFA-l; further, such a ligand cannot be the LFA-l itself, since the 
possibility of like-like recognition in which LFA-I on one cell 
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Figure 7. Immunogold labeling in scanning electron microscopy of epi-
dermal cells. A: Langerhans cell labeled with an anti-CDllb moAb is appre-
ciable. In fact. gold particles (white dots) are visible on the cell surface. 
Bar = 1 j1.m. B: Numerous gold particles (white dots) are visible on the sur-
face of a Langerhans cell labeled with the anti-CDllc moAb. Bar = 1 j1.m . 
c: Immunogold staining in scanning electron mkroscopy of epidermal cells 
with unreactive mouse IgG of appropriate isotype instead of moAb (negative 
control). The morphological details reveal that the epidermal cell on the left 
is a keratinocyte. while the epidermal cell on the right is a Langerhans cell. 
No gold particles are visible on the surface of both epidermal cells. Bar = 
lj1.m. 
might bind LFA-I on another cell seems to have been ruled out 
[5,52]. Therefore, a presence ofLFA-l on the membrane ofLC does 
not seem necessary for the LC antigen presenting function. On the 
other hand, LC functions. for which adhesive properties are re-
quired. can well be subserved by the expression on the LC mem-
brane of the other two members of the adherence-promoting 
CD11/CD18 family, namely H-Mac-1 and gp 150,95, as shown 
here. 
In this investigation, we extend our previous data [43] suggesting 
the expression of the CDIIb subunit on the membrane of human 
resting LC. By contrast, the majority of the data reported by several 
investigators failed to detect anti-CDIIb reactive dendritic EC in 
normal human skin [53 - 57]. Indeed, such investigations were per-
formed on immunohistological frozen sections [53 - 57]; thus, it 
seems likely that the limited amounts of exposed antigenic moieties 
could escape detection by such conventional staining procedures 
[58]. In fact. all the observed LC showed their clear, although weak. 
CDIIb-positivity when more-sensitive techniques were used, such 
as the IG-TEM procedure [35,36,42], and, even to a higher extent, 
the IG-SEM procedure [37,38]. Further, since LC are the only 
HLA-DR-positive EC [59,60], the double-staining IG-TEM exper-
iments confirmed that all the HLA-DR-positive EC also were 
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Table II. Density Per Cell Section (Midplane) of Gold Particles 
Bound to the Plasma Membrane of Langerhans Cells 
Labeled with Monoclonal Antibodies Detecting the 
Subunits of the CDtl/CDI8 Family 
(Transmission Electron Microscopy Examination) 
moAb 
TS1/22.1.l.17 
MHM24 
Anti-Leu-15 
60.1 
OK.Ml 
Anti-C3bi 
Anti-Leu-M5 
60.3 
Anti-COlla 
Anti-CDllb 
Anti-COll e 
Anti-CD18 
Number of Examined 
LC Sections 
40 
40 
40 
40 
40 
40 
40 
40 
80 
160 
40 
40 
Number of Gold Particles 
per LC Section (m ± sd) 
0.4 ± 0.7 
0.2 ± 0.5 
5.0 ± 6.5 
7.6 ± 4.6 
3.8 ± 3.1 
11.3±17.5 
35.0 ± 27.7 
7.5 ± 4.9 
0.3 ± 0.6 
6.9 ± 10.1 
35.0 ± 27.7 
7.5 ± 4.9 
CDllb-positive. Finally, our in situ lEM studies on slightly pre-
fixed skin sections recently confirmed the CDlib staining even of 
unseparated LC [41]. 
Here we demonstrate, confirming our preliminary findings [44], 
that human resting epidermal LC express considerable amounts of 
CDltc. In fact, not only the highly sensitive IG-lEM methods, but 
also the IF and LM immunostainings clearly revealed the Leu-M5 
(CDl1c) positivity of LC. Using a different anti-CDllc moAb, 
named 3.9, and a conventional indirect IP method in LM, others 
apparently failed to detect LC in skin sections, but revealed 3.9-
positive LC in expanded skin Iymphnodes from samples of derma-
topathic lymphadenopathy [24] . In agreement with our results, 
another report [61] claimed the LM immunocytochemical CDllc 
staining of epidermal dendritic cells, using both the same moAb 
used by us (SHCL3) and another anti-CDllc moAb, namely KB90. 
Further, the KB90 reactivity of epidermal dendritic cells was 
strongly evident, and was even more consistent than the stainings of 
the same cells obtained using a large panel of moAb detecting other 
antigens [61] . In addition, the semiquantitative analysis performed 
here clearly stated that a high number of gold granules decorated the 
membrane ofIG-labeled CDllc-positive LC (Figs 3,6B,7B). Since 
it is well established that the number of antigenic sites may be, 
although indirectly, estimated by the densities of gold particles 
bound to the cell surface [62], it is tempting to conclude that the 
CDl1c expression by LC, revealed by high densities ofIG labelings 
and by even conventional immunocytochemical LM irnmunostain-
ings, is strong indeed. 
Finally, the current study assesses the expression of CD18 by 
human restin~ LC. Such an expression, which confirms our prelim-
inary results [45], is not surprising, since virtually all leukocytes 
are known to certainly bear the CD18 moiety [6,7,12,25 -28], and 
was therefore expected on LC, which are certainly considered 
leukocytes [30,31 J. 
Functional studies are clearly needed to elucidate the role of the 
adhesive molecules H-Mac-1 (CD11b/CD18) and gp 150,95 
~CDllc/CDI8} on the membrane of human resting LC. Such stud-
Ies, however, were not the purpose of the present investigation. 
Nevertheless, it is presumable that such molecules could play on 
the LC surface the same functional roles they are known to play on 
the membrane of other leukocytes. Indeed, both H-Mac-l and gp 
150,95 have a dual function, as adhesion molecules in (l}'cell-cell 
and (2) cell-substrate interactions. In this respect, it is tempting to 
speculate that the H-Mac-l and gp 150,95 expressions by the LC 
plasma membrane could serve (I) promoting interactions between 
LC and other cells, and (2) guiding the migration and localization 
ofLC. 
In fact, it is now well established that both H-Mac-l and gp 
150,95 are able to mediate intercellular adhesion among leukocytes, 
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and are required for an efficient contact between effector cells and 
their corresponding targets [12,22,27]. Interestingly, the physical 
association of dendritic cells and T-Iymphocytes, which is required 
for primary immune responses and precedes and is essential for 
T-cell activation [63], is inhibited by the anti-CDl8 moAb [28]' 
(The CD18 moiety, as mentioned above, is a part of both H-Mac-l 
and gp 150,95 molecules.) Such an observation could suggest a role 
for adhesive proteins of the CDll/CDI8 family even in the anti-
gen-presenting process. On the other hand, the importance of phys-
ical conjugates formed in situ between LC and lymphocytes, pre-
sumably necessary for the antigen presentation, has been well 
known for many years [64-66] . It seems therefore tempting to 
hypothesize that the presence of the adhesion-promoting CDllb/ 
CD18 and CDllc/CDI8 receptors on LC could subserve, eventu-
ally together with other ligand-receptor interactions, adherence be-
tween LC and T -lymphocytes, therefore contributing to an 
efficient antigen presentation. 
A considerable amount of evidence is accumulating that both 
H-Mac-l and gp 150,95 subserve leukocyte-substrate adhesion, 
spreading, directed motility and tissue localization [17,23 - 26]. 
H-Mac-l seems particularly important for the recruitment of 
monocytic cells to inflammatory stimules [16]. The differentiation 
of blood monocytes to tissue macrophages results in greatly increased 
cell surface expression of gp 150,95 [17,23,24], thus regulating the 
monocyte ability to adhere to endothelial cells, diapedese and local-
ize in various organs as tissue macrophages [17]. On the other hand, 
LC, derived from bone marrow [29], are able to travel from the 
blood to their cutaneous residence. Interestingly, a subset of mono-
nuclear cells in peripheral blood of extensively borned subjects, 
thought to represent LC precursors migrating from their bone-mar-
row. ~rigin to the skin, expressed high amounts ofH-Mac-l [67] . In 
addltlOn, LC are able to migrate from the epidermis to the dermis 
and de~mal lymphatiCS during immunological reactions involving 
the SklO [66,68J. It is tempting therefore to speculate that the 
H-Mac-l and gp 150,95 moieties expressed on the membrane ofLC 
co.uld ~uide, as well as demonstrated for monocyte-macrophage 
migration and localization, the migration and localization of LC. 
In conclusion, although functional studies are necessary to clarify 
the role of the second (H-Mac-l) and the third (gp 150,95) mem-
bers of the adherence-subserving CDl1/C018 family on the sur-
face of LC, such expressions could promote those LC functions 
which are related both to LC adherence to other cell types and to LC 
migration and localization. 
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